Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Phase I Safety & Pharmacokinetics (NCT02637284) In December 2015, a Phase I trial was registered on ClinicalTrials.gov (NCT02637284) by PharmaCotherapia d.o.o
Messlinger K
Zero Risk Protocol Purity guaranteed or your money back
Promotes tendon and ligament repair
Benefits include: Accurate dosing Ease of use Reduced discomfort Improved consistency Dosage Recommendations 6 clicks per dose (250mcg) Approximately 40 doses per pen For best results, use consistently alongside proper recovery strategies
Inhaling glutathione may trigger asthma attacks in asthmatics
US$ 22.29
US$ 21.37
US$ 27.43
US$ 28.13
US$ 22.79
US$ 19.98
US$ 24.03
US$ 28.50
US$ 21.77
US$ 22.19
